Norepinephrine-glucocorticoids interaction does not annul the opposite effects of the individual treatments on cellular plasticity in neuroblastoma cells

European Journal of Pharmacology

Volumn 596, Issue 1-3, 2008, Pages 14-24

  Yaniv, Shiri P ^a   Ben Shachar, Dorit ^a   Klein, Ehud ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Glucocorticoid; Human neuroblastoma SH SY5Y cell; Major depression; Neuronal plasticity; Norepinephrine

Indexed keywords

ANTIDEPRESSANT AGENT; BIOLOGICAL MARKER; CALGRANULIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DEXAMETHASONE; LAMININ; MESSENGER RNA; MONOAMINE; NEUROMODULIN; NORADRENALIN;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; MAJOR DEPRESSION; NERVE CELL PLASTICITY; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; UPREGULATION;

CELL LINE, TUMOR; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DEXAMETHASONE; DRUG INTERACTIONS; GAP-43 PROTEIN; GLUCOCORTICOIDS; HUMANS; LAMININ; NEURAL CELL ADHESION MOLECULE L1; NEURONAL PLASTICITY; NOREPINEPHRINE; RECEPTORS, GLUCOCORTICOID;

EID: 53249100299     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.08.006     Document Type: Article

References (65)

1. Alblas J., van Corven E.J., Hordijk P.L., Milligan G., and Moolenaar W.H. Gi-mediated activation of the p21ras-mitogen-activated protein kinase pathway by alpha 2-adrenergic receptors expressed in fibroblasts. J. Biol. Chem. 268 (1993) 22235-22238
2. Appelhof B.C., Huyser J., Verweij M., Brouwer J.P., van Dyck R., Fliers E., Hoogendijk W.J., Tijssen J.G., Wiersinga W.M., and Schene A.H. Glucocorticoids and relapse of major depression (dexamethasone/corticotropin-releasing hormone test in relation to relapse of major depression). Biol. Psychiatry 59 (2006) 696-701
3. Arango V., Underwood M.D., and Mann J.J. Fewer pigmented locus coeruleus neurons in suicide victims: preliminary results. Biol. Psychiatry 39 (1996) 112-120
4. Berardi M., Hindelang C., Felix J.M., and Stoeckel M.E. L1 and laminin: their expression during rat hypophysis ontogenesis and in adult neurohemal areas. Int. J. Dev. Neurosci. 17 (1999) 121-130
5. Bremner J.D., Krystal J.H., Southwick S.M., and Charney D.S. Noradrenergic mechanisms in stress and anxiety: I. Preclinical studies. Synapse (New York, N.Y.) 23 (1996) 28-38
6. Cotecchia S., Kobilka B.K., Daniel K.W., Nolan R.D., Lapetina E.Y., Caron M.G., Lefkowitz R.J., and Regan J.W. Multiple second messenger pathways of alpha-adrenergic receptor subtypes expressed in eukaryotic cells. J. Biol. Chem. 265 (1990) 63-69
7. Cryan J.F., O'Leary O.F., Jin S.H., Friedland J.C., Ouyang M., Hirsch B.R., Page M.E., Dalvi A., Thomas S.A., and Lucki I. Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 8186-8191
8. Davis S., Vanhoutte P., Pages C., Caboche J., and Laroche S. The MAPK/ERK cascade targets both Elk-1 and cAMP response element-binding protein to control long-term potentiation-dependent gene expression in the dentate gyrus in vivo. J. Neurosci. 20 (2000) 4563-4572
9. De Kloet E.R., Vreugdenhil E., Oitzl M.S., and Joels M. Brain corticosteroid receptor balance in health and disease. Endocr. Rev. 19 (1998) 269-301
10. Dowlatshahi D., MacQueen G.M., Wang J.F., and Young L.T. Increased temporal cortex CREB concentrations and antidepressant treatment in major depression. Lancet 352 (1998) 1754-1755
11. Duman R.S. Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromolecular med. 5 (2004) 11-25
12. Duman R.S., Malberg J., and Thome J. Neural plasticity to stress and antidepressant treatment. Biol. Psychiatry 46 (1999) 1181-1191
13. Dwivedi Y., Rao J.S., Rizavi H.S., Kotowski J., Conley R.R., Roberts R.C., Tamminga C.A., and Pandey G.N. Abnormal expression and functional characteristics of cyclic adenosine monophosphate response element binding protein in postmortem brain of suicide subjects. Arch. Gen. Psychiatry 60 (2003) 273-282
14. Flugge G. Effects of cortisol on brain alpha2-adrenoceptors: potential role in stress. Neurosci. Biobehav. Rev. 23 (1999) 949-956
15. Flugge G., van Kampen M., Meyer H., and Fuchs E. Alpha2A and alpha2C-adrenoceptor regulation in the brain: alpha2A changes persist after chronic stress. Eur. J. Neurosci. 17 (2003) 917-928
16. Foy M.R., Stanton M.E., Levine S., and Thompson R.F. Behavioral stress impairs long-term potentiation in rodent hippocampus. Behav. Neural Biol. 48 (1987) 138-149
17. Gormley G.J., Lowy M.T., Reder A.T., Hospelhorn V.D., Antel J.P., and Meltzer H.Y. Glucocorticoid receptors in depression: relationship to the dexamethasone suppression test. Am. J. Psychiatry 142 (1985) 1278-1284
18. Hajszan T., MacLusky N.J., and Leranth C. Short-term treatment with the antidepressant fluoxetine triggers pyramidal dendritic spine synapse formation in rat hippocampus. Eur. J. Neurosci. 21 (2005) 1299-1303
19. Hall H., Carbonetto S., and Schachner M. L1/HNK-1 carbohydrate- and beta 1 integrin-dependent neural cell adhesion to laminin-1. J. Neurochem. 68 (1997) 544-553
20. Haynes L.E., Barber D., and Mitchell I.J. Chronic antidepressant medication attenuates dexamethasone-induced neuronal death and sublethal neuronal damage in the hippocampus and striatum. Brain Res. 1026 (2004) 157-167
21. Holderbach R., Clark K., Moreau J.L., Bischofberger J., and Normann C. Enhanced long-term synaptic depression in an animal model of depression. Biol. Psychiatry 62 (2007) 92-100
22. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23 (2000) 477-501
23. Jacobs C.M., Trinh M.D., Rootwelt T., Lomo J., and Paulsen R.E. Dexamethasone induces cell death which may be blocked by NMDA receptor antagonists but is insensitive to Mg2+ in cerebellar granule neurons. Brain Res. 1070 (2006) 116-123
24. Kamiguchi H., and Lemmon V. Neural cell adhesion molecule L1: signaling pathways and growth cone motility. J. Neurosci. Res. 49 (1997) 1-8
25. Kassel O., Sancono A., Kratzschmar J., Kreft B., Stassen M., and Cato A.C. Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO J. 20 (2001) 7108-7116
26. Kempermann G., and Kronenberg G. Depressed new neurons-adult hippocampal neurogenesis and a cellular plasticity hypothesis of major depression. Biol. Psychiatry 54 (2003) 499-503
27. Kim J.B., Ju J.Y., Kim J.H., Kim T.Y., Yang B.H., Lee Y.S., and Son H. Dexamethasone inhibits proliferation of adult hippocampal neurogenesis in vivo and in vitro. Brain Res. 1027 (2004) 1-10
28. Kovachich G.B., Frazer A., and Aronson C.E. Effect of chronic administration of antidepressants on alpha 2-adrenoceptors in the locus coeruleus and its projection fields in rat brain determined by quantitative autoradiography. Neuropsychopharmacology 8 (1993) 57-65
29. Krugers H.J., Goltstein P.M., van der Linden S., and Joels M. Blockade of glucocorticoid receptors rapidly restores hippocampal CA1 synaptic plasticity after exposure to chronic stress. Eur. J. Neurosci. 23 (2006) 3051-3055
30. Laifenfeld D., Klein E., and Ben-Shachar D. Norepinephrine alters the expression of genes involved in neuronal sprouting and differentiation: relevance for major depression and antidepressant mechanisms. J. Neurochem. 83 (2002) 1054-1064
31. Laifenfeld D., Karry R., Grauer E., Klein E., and Ben-Shachar D. Antidepressants and prolonged stress in rats modulate CAM-L1, laminin, and pCREB, implicated in neuronal plasticity. Neurobiol. Dis. 20 (2005) 432-441
32. Laifenfeld D., Karry R., Klein E., and Ben-Shachar D. Alterations in cell adhesion molecule L1 and functionally related genes in major depression: a postmortem study. Biol. Psychiatry 57 (2005) 716-725
33. Luthl A., Laurent J.P., Figurov A., Muller D., and Schachner M. Hippocampal long-term potentiation and neural cell adhesion molecules L1 and NCAM. Nature 372 (1994) 777-779
34. Malberg J.E., Eisch A.J., Nestler E.J., and Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J. Neurosci. 20 (2000) 9104-9110
35. Manji H.K., Moorie G.J., Rajkovska G., and Chen G. Neuroplasticity and cellular resilience in mood disorders. Mol. Psychiatry 55 (2000) 78-93
36. McEwen B.S. Stress and hippocampal plasticity. Annu. Rev. Neurosci. 22 (1999) 105-122
37. Muller M.B., Lucassen P.J., Yassouridis A., Hoogendijk W.J., Holsboer F., and Swaab D.F. Neither major depression nor glucocorticoid treatment affects the cellular integrity of the human hippocampus. Eur. J. Neurosci. 14 (2001) 1603-1612
38. Murphy N.P., Ball S.G., and Vaughan P.F. Potassium- and carbachol-evoked release of [3H]noradrenaline from human neuroblastoma cells, SH-SY5Y. J. Neurochem. 56 (1991) 1810-1815
39. Nakagawa S., Kim J.E., Lee R., Malberg J.E., Chen J., Steffen C., Zhang Y.J., Nestler E.J., and Duman R.S. Regulation of neurogenesis in adult mouse hippocampus by cAMP and the cAMP response element-binding protein. J. Neurosci. 22 (2002) 3673-3682
40. Nestler E.J., McMahon A., Sabban E.L., Tallman J.F., and Duman R.S. Chronic antidepressant administration decreases the expression of tyrosine hydroxylase in the rat locus coeruleus. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 7522-7526
41. Nibuya M., Nestler E.J., and Duman R.S. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J. Neurosci. 16 (1996) 2365-2372
42. Ordway G.A., Schenk J., Stockmeier C.A., May W., and Klimek V. Elevated agonist binding to alpha2-adrenoceptors in the locus coeruleus in major depression. Biol. Psychiatry 53 (2003) 315-323
43. Pahlman S., Mamaeva S., Meyerson G., Mattsson M.E., Bjelfman C., Ortoft E., and Hammerling U. Human neuroblastoma cells in culture: a model for neuronal cell differentiation and function. Acta Physiol. Scand. 592 (1990) 25-37
44. Parsley S., Gazi L., Bobirnac I., Loetscher E., and Schoeffter P. Functional alpha2C-adrenoceptors in human neuroblastoma SH-SY5Y cells. Eur. J. Pharmacol. 372 (1999) 109-115
45. Pesce M., and Scholer H.R. Oct-4: gatekeeper in the beginnings of mammalian development. Stem Cells 19 (2001) 271-278
46. Peters M.J., Adcock I.M., Brown C.R., and Barnes P.J. Beta-adrenoceptor agonists interfere with glucocorticoid receptor DNA binding in rat lung. Eur. J. Pharmacol. 289 (1995) 275-281
47. Petty F., Kramer G., Wilson L., and Chae Y.L. Learned helplessness and in vivo hippocampal norepinephrine release. Pharmacol. Biochem. Behav. 46 (1993) 231-235
48. Rajkowska G., Miguel-Hidalgo J.J., Wei J., Dilley G., Pittman S.D., and Meltzer H.Y. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol. Psychiatry 45 (1999) 1085-1098
49. Rantamaki T., Hendolin P., Kankaanpaa A., Mijatovic J., Piepponen P., Domenici E., Chao M.V., Mannisto P.T., and Castren E. Pharmacologically diverse antidepressants rapidly activate brain-derived neurotrophic factor receptor TrkB and induce phospholipase-Cgamma signaling pathways in mouse brain. Neuropsychopharmacology 32 (2007) 2152-2162
50. Reul J.M., Stec I., Soder M., and Holsboer F. Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system. Endocrinology 133 (1993) 312-320
51. Saarelainen T., Hendolin P., Lucas G., Koponen E., Sairanen M., MacDonald E., Agerman K., Haapasalo A., Nawa H., Aloyz R., Ernfors P., and Castren E. Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. J. Neurosci. 23 (2003) 349-357
52. Sairanen M., O'Leary O.F., Knuuttila J.E., and Castren E. Chronic antidepressant treatment selectively increases expression of plasticity-related proteins in the hippocampus and medial prefrontal cortex of the rat. Neuroscience 144 (2007) 368-374
53. Sapolsky R.M. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch. Gen. Psychiatry 57 (2000) 925-935
54. Sheehan J., Eischeid A., Saunders R., and Pouratian N. Potentiation of neurite outgrowth and reduction of apoptosis by immunosuppressive agents: implications for neuronal injury and transplantation. Neurosurg. Focus 20 (2006) E9
55. Sheline Y.I., Wang P.W., Galdo M.H., Csernansky J.G., and Vannier M.W. Hippocampal atrophy in recurrent major depression. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 3908-3913
56. Taraviras S., Olli-Lahdesmaki T., Lymperopoulos A., Charitonidou D., Mavroidis M., Kallio J., Scheinin M., and Flordellis C. Subtype-specific neuronal differentiation of PC12 cells transfected with alpha2-adrenergic receptors. Eur. J. Cell Biol. 81 (2002) 363-374
57. Tardito D., Perez J., Tiraboschi E., Musazzi L., Racagni G., and Popoli M. Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: a critical overview. Pharmacol. Rev. 58 (2006) 115-134
58. Timpl R., and Brown J.C. The laminins. Matrix Biol. 14 (1994) 275-281
59. Wodarz N., Rupprecht R., Kornhuber J., Schmitz B., Wild K., and Riederer P. Cell-mediated immunity and its glucocorticoid-sensitivity after clinical recovery from severe major depressive disorder. J. Affect. Disord. 25 (1992) 31-38
60. Yamada S., Yamamoto M., Ozawa H., Riederer P., and Saito T. Reduced phosphorylation of cyclic AMP-responsive element binding protein in the postmortem orbitofrontal cortex of patients with major depressive disorder. J. Neural Transm. 110 (2003) 671-680
61. Yu I.T., Lee S.H., Lee Y.S., and Son H. Differential effects of corticosterone and dexamethasone on hippocampal neurogenesis in vitro. Biochem. Biophys. Res. Commun. 317 (2004) 484-490
62. Zhang Y., Bo X., Schoepfer R., Holtmaat A.J., Verhaagen J., Emson P.C., Lieberman A.R., and Anderson P.N. Growth-associated protein GAP-43 and L1 act synergistically to promote regenerative growth of Purkinje cell axons in vivo. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 14883-14888
63. Zhao Z., Baros A.M., Zhang H.T., Lapiz M.D., Bondi C.O., Morilak D.A., and O'Donnell J.M. Norepinephrine transporter regulation mediates the long-term behavioral effects of the antidepressant desipramine. Neuropsychopharmacology (2008) (Advanced online publication)
64. Zhu M.Y., Klimek V., Dilley G.E., Haycock J.W., Stockmeier C., Overholser J.C., Meltzer H.Y., and Ordway G.A. Elevated levels of tyrosine hydroxylase in the locus coeruleus in major depression. Biol. Psychiatry 46 (1999) 1275-1286
65. Zor T., and Selinger Z. Linearization of the Bradford protein assay increases its sensitivity: theoretical and experimental studies. Anal. Biochem. 236 (1996) 302-308